Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1911-1920 of 2869 for cancer

Edit search filters
  1. A Phase 2, Multi-center, Open-label Study To Evaluate The Efficacy And Safety Of Luspatercept (ACE-536) In Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis And Anemia With And Without Red Blood Cell-Transfusion Dependence

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  2. A Study Of Caplacizumab In Patients With Acquired Thrombotic Thrombocytopenic Purpura

    Rochester, MN

  3. Early Detection of Hemodynamic Decompensation in Humans

    Rochester, MN

  4. The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies

    Scottsdale/Phoenix, AZ

  5. A Study To Assess The Safety And Pharmacokinetics Of GDC-8264 In Combination With Standard Of Care In Participants With Acute Graft-Versus-Host Disease (AGVHD)

    Rochester, MN

  6. Using Laser Endomicroscopy to Predict Recurrence of Barrett's Esophagus

    Rochester, MN

  7. A Study To Assess The MEK Inhibitor Mirdametinib (PD-0325901) In Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. A Study Of Using Mesenchymal Stem Cells Developed From The Patients Own Fat Tissue For Reducing Hemodialysis Arteriovenous Fistula Failure

    Rochester, MN

  9. A Study Of The Outcomes Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease

    Rochester, MN

  10. A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD

    Jacksonville, FL

.

Mayo Clinic Footer